Le Lézard
Classified in: Business
Subject: STR

Canadian Investment Regulatory Organization Trade Resumption - SXL


VANCOUVER, BC, Oct. 12, 2023 /CNW/ - Trading resumes in:

Company: SLAM Exploration Ltd.

TSX-Venture Symbol: SXL 

All Issues: Yes

Resumption (ET): 12:30 PM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) ? Halts/Resumptions


These press releases may also interest you

at 23:09
TSX VENTURE COMPANIES BULLETIN V2024-1261 AMERICAN LITHIUM CORP. ("LI.WT")BULLETIN TYPE:  Warrant Expiry-DelistBULLETIN DATE:  May 1, 2024TSX Venture Tier 2 Company Effective at the opening, May 9, 2024, the Share Purchase Warrants of the Company...

at 22:30
Airbus Canada Limited Partnership (Airbus Canada) is pleased to announce that it has reached a labour agreement with the 1,300 unionized employees at its Mirabel site, in Quebec. After several months of negotiations, the employees who assemble the...

at 22:24
Caribbean Utilities Company, Ltd. ("CUC or "the Company") announced its consolidated unaudited results for the three months ended March 31, 2024 ("First Quarter 2024" or "Q1 2024") (all figures stated in United States Dollars)....

at 21:45
Pangea Entertainment Productions (Venice, Ca.) and Big Bang Mediaverse (Mumbai, India) announce a partnership to create and produce innovative multiplatform content aimed at younger and connected audiences globally and in India. The first program in...

at 21:41
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Akero Therapeutics, Inc. ("Akero" or "the Company") and certain of its officers....

at 21:30
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc.  today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and Poseida have entered into a...



News published on and distributed by: